Toll-Like Receptor 2 (TLR2) Polymorphisms Are Associated with Reversal Reaction in Leprosy

Background. Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may undergo immunological changes known as “reactional states” (reversal reaction and erythema nodosum leprosum) that result in major clinical deter...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 197; no. 2; pp. 253 - 261
Main Authors Bochud, Pierre-Yves, Hawn, Thomas R., Siddiqui, M. Ruby, Saunderson, Paul, Britton, Sven, Abraham, Isaac, Argaw, Azeb Tadesse, Janer, Marta, Zhao, Lue Ping, Kaplan, Gilla, Aderem, Alan
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 15.01.2008
University of Chicago Press
Subjects
Online AccessGet full text
ISSN0022-1899
1537-6613
DOI10.1086/524688

Cover

Abstract Background. Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may undergo immunological changes known as “reactional states” (reversal reaction and erythema nodosum leprosum) that result in major clinical deterioration. The goal of the present study was to assess the effect of Toll-like receptor 2 (TLR2) polymorphisms on susceptibility to and clinical presentation of leprosy. Methods. Three polymorphisms in TLR2 (597C→T, 1350T→C, and a microsatellite marker) were analyzed in 431 Ethiopian patients with leprosy and 187 control subjects. The polymorphism-associated risk of developing leprosy, lepromatous (vs. tuberculoid) leprosy, and leprosy reactions was assessed by multivariate logistic regression models. Results. The microsatellite and the 597C→T polymorphisms both influenced susceptibility to reversal reaction. Although the 597T allele had a protective effect (odds ratio [OR], 0.34 [95% confidence interval {CI}, 0.17–0.68]; P = .002 under the dominant model), homozygosity for the 280-bp allelic length of the microsatellite strongly increased the risk of reversal reaction (OR, 5.83 [95% CI, 1.98–17.15]; P = .001 under the recessive model). These associations were consistent among 3 different ethnic groups. Conclusions. These data suggest a significant role for TLR-2 in the occurrence of leprosy reversal reaction and provide new insights into the immunogenetics of the disease.
AbstractList Background. Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may undergo immunological changes known as "reactional states" (reversal reaction and erythema nodosum leprosum) that result in major clinical deterioration. The goal of the present study was to assess the effect of Toll-like receptor 2 (TLR2) polymorphisms on susceptibility to and clinical presentation of leprosy. Methods. Three polymorphisms in TLR2 (597C→T, 1350T→C, and a microsatellite marker) were analyzed in 431 Ethiopian patients with leprosy and 187 control subjects. The polymorphism-associated risk of developing leprosy, lepromatous (vs. tuberculoid) leprosy, and leprosy reactions was assessed by multivariate logistic regression models. Results. The microsatellite and the 597C→T polymorphisms both influenced susceptibility to reversal reaction. Although the 597T allele had a protective effect (odds ratio [OR], 0.34 [95% confidence interval {CI}, 0.17-0.68]; P = .002 under the dominant model), homozygosity for the 280-bp allelic length of the microsatellite strongly increased the risk of reversal reaction (OR, 5.83 [95% CI, 1.98-17.15]; P = .001 under the recessive model). These associations were consistent among 3 different ethnic groups. Conclusions. These data suggest a significant role for TLR-2 in the occurrence of leprosy reversal reaction and provide new insights into the immunogenetics of the disease.
Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may undergo immunological changes known as "reactional states" (reversal reaction and erythema nodosum leprosum) that result in major clinical deterioration. The goal of the present study was to assess the effect of Toll-like receptor 2 (TLR2) polymorphisms on susceptibility to and clinical presentation of leprosy.BACKGROUNDLeprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may undergo immunological changes known as "reactional states" (reversal reaction and erythema nodosum leprosum) that result in major clinical deterioration. The goal of the present study was to assess the effect of Toll-like receptor 2 (TLR2) polymorphisms on susceptibility to and clinical presentation of leprosy.Three polymorphisms in TLR2 (597C-->T, 1350T-->C, and a microsatellite marker) were analyzed in 431 Ethiopian patients with leprosy and 187 control subjects. The polymorphism-associated risk of developing leprosy, lepromatous (vs. tuberculoid) leprosy, and leprosy reactions was assessed by multivariate logistic regression models.METHODSThree polymorphisms in TLR2 (597C-->T, 1350T-->C, and a microsatellite marker) were analyzed in 431 Ethiopian patients with leprosy and 187 control subjects. The polymorphism-associated risk of developing leprosy, lepromatous (vs. tuberculoid) leprosy, and leprosy reactions was assessed by multivariate logistic regression models.The microsatellite and the 597C-->T polymorphisms both influenced susceptibility to reversal reaction. Although the 597T allele had a protective effect (odds ratio [OR], 0.34 [95% confidence interval {CI}, 0.17-0.68]; P= .002 under the dominant model), homozygosity for the 280-bp allelic length of the microsatellite strongly increased the risk of reversal reaction (OR, 5.83 [95% CI, 1.98-17.15]; P= .001 under the recessive model). These associations were consistent among 3 different ethnic groups.RESULTSThe microsatellite and the 597C-->T polymorphisms both influenced susceptibility to reversal reaction. Although the 597T allele had a protective effect (odds ratio [OR], 0.34 [95% confidence interval {CI}, 0.17-0.68]; P= .002 under the dominant model), homozygosity for the 280-bp allelic length of the microsatellite strongly increased the risk of reversal reaction (OR, 5.83 [95% CI, 1.98-17.15]; P= .001 under the recessive model). These associations were consistent among 3 different ethnic groups.These data suggest a significant role for TLR-2 in the occurrence of leprosy reversal reaction and provide new insights into the immunogenetics of the disease.CONCLUSIONSThese data suggest a significant role for TLR-2 in the occurrence of leprosy reversal reaction and provide new insights into the immunogenetics of the disease.
Background. Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may undergo immunological changes known as "reactional states" (reversal reaction and erythema nodosum leprosum) that result in major clinical deterioration. The goal of the present study was to assess the effect of Toll-like receptor 2 (TLR2) polymorphisms on susceptibility to and clinical presentation of leprosy. Methods. Three polymorphisms in TLR2 (597C→T, 1350T→C, and a microsatellite marker) were analyzed in 431 Ethiopian patients with leprosy and 187 control subjects. The polymorphism-associated risk of developing leprosy, lepromatous (vs. tuberculoid) leprosy, and leprosy reactions was assessed by multivariate logistic regression models. Results. The microsatellite and the 597C→T polymorphisms both influenced susceptibility to reversal reaction. Although the 597T allele had a protective effect (odds ratio [OR], 0.34 [95% confidence interval {CI}, 0.17-0.68]; P= .002 under the dominant model), homozygosity for the 280-bp allelic length of the microsatellite strongly increased the risk of reversal reaction (OR, 5.83 [95% CI, 1.98-17.15]; P= .001 under the recessive model). These associations were consistent among 3 different ethnic groups. Conclusions. These data suggest a significant role for TLR-2 in the occurrence of leprosy reversal reaction and provide new insights into the immunogenetics of the disease.
Background. Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may undergo immunological changes known as "reactional states" (reversal reaction and erythema nodosum leprosum) that result in major clinical deterioration. The goal of the present study was to assess the effect of Toll-like receptor 2 (TLR2) polymorphisms on susceptibility to and clinical presentation of leprosy. Methods. Three polymorphisms in TLR2 (597C1T, 1350T1C, and a microsatellite marker) were analyzed in 431 Ethiopian patients with leprosy and 187 control subjects. The polymorphism-associated risk of developing leprosy, lepromatous (vs. tuberculoid) leprosy, and leprosy reactions was assessed by multivariate logistic regression models. Results. The microsatellite and the S97C1T polymorphisms both influenced susceptibility to reversal reaction. Although the 597T allele had a protective effect (odds ratio [OR], 0.34 [95% confidence interval {CI}, 0.17-0.68]; P = .002 under the dominant model), homozygosity for the 280-bp allelic length of the microsatellite strongly increased the risk of reversal reaction (OR, 5.83 [95% a, 1.98-17.15]; P .001 under the recessive model). These associations were consistent among 3 different ethnic groups. Conclusions. These data suggest a significant role for TLR-2 in the occurrence of leprosy reversal reaction and provide new insights into the immunogenetics of the disease.
Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may undergo immunological changes known as "reactional states" (reversal reaction and erythema nodosum leprosum) that result in major clinical deterioration. The goal of the present study was to assess the effect of Toll-like receptor 2 (TLR2) polymorphisms on susceptibility to and clinical presentation of leprosy. Three polymorphisms in TLR2 (597C-->T, 1350T-->C, and a microsatellite marker) were analyzed in 431 Ethiopian patients with leprosy and 187 control subjects. The polymorphism-associated risk of developing leprosy, lepromatous (vs. tuberculoid) leprosy, and leprosy reactions was assessed by multivariate logistic regression models. The microsatellite and the 597C-->T polymorphisms both influenced susceptibility to reversal reaction. Although the 597T allele had a protective effect (odds ratio [OR], 0.34 [95% confidence interval {CI}, 0.17-0.68]; P= .002 under the dominant model), homozygosity for the 280-bp allelic length of the microsatellite strongly increased the risk of reversal reaction (OR, 5.83 [95% CI, 1.98-17.15]; P= .001 under the recessive model). These associations were consistent among 3 different ethnic groups. These data suggest a significant role for TLR-2 in the occurrence of leprosy reversal reaction and provide new insights into the immunogenetics of the disease.
Author Britton, Sven
Hawn, Thomas R.
Saunderson, Paul
Abraham, Isaac
Zhao, Lue Ping
Bochud, Pierre-Yves
Argaw, Azeb Tadesse
Janer, Marta
Aderem, Alan
Siddiqui, M. Ruby
Kaplan, Gilla
AuthorAffiliation 3 Quantitative Genetic Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle
2 Department of Medicine, University of Washington, Seattle
6 Armauer Hansen Research Institute, Addis Ababa, Ethiopia
5 All-Africa Leprosy Rehabilitation and Training Centre
4 Public Health Research Institute, Laboratory of Mycobacterial Immunity and Pathogenesis, University of Medicine and Dentistry of New Jersey, Newark
1 Institute for Systems Biology, University of Washington, Seattle
AuthorAffiliation_xml – name: 2 Department of Medicine, University of Washington, Seattle
– name: 6 Armauer Hansen Research Institute, Addis Ababa, Ethiopia
– name: 1 Institute for Systems Biology, University of Washington, Seattle
– name: 3 Quantitative Genetic Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle
– name: 5 All-Africa Leprosy Rehabilitation and Training Centre
– name: 4 Public Health Research Institute, Laboratory of Mycobacterial Immunity and Pathogenesis, University of Medicine and Dentistry of New Jersey, Newark
Author_xml – sequence: 1
  givenname: Pierre-Yves
  surname: Bochud
  fullname: Bochud, Pierre-Yves
  email: pyb@systemsbiology.org
  organization: Institute for Systems Biology, Fred Hutchinson Cancer Research Center, Seattle
– sequence: 2
  givenname: Thomas R.
  surname: Hawn
  fullname: Hawn, Thomas R.
  organization: Institute for Systems Biology, Fred Hutchinson Cancer Research Center, Seattle
– sequence: 3
  givenname: M. Ruby
  surname: Siddiqui
  fullname: Siddiqui, M. Ruby
  organization: Public Health Research Institute, Laboratory of Mycobacterial Immunity and Pathogenesis, University of Medicine and Dentistry of New Jersey, Newark
– sequence: 4
  givenname: Paul
  surname: Saunderson
  fullname: Saunderson, Paul
  organization: All-Africa Leprosy Rehabilitation and Training Centre, Addis Ababa, Ethiopia
– sequence: 5
  givenname: Sven
  surname: Britton
  fullname: Britton, Sven
  organization: Armauer Hansen Research Institute, Addis Ababa, Ethiopia
– sequence: 6
  givenname: Isaac
  surname: Abraham
  fullname: Abraham, Isaac
  organization: Armauer Hansen Research Institute, Addis Ababa, Ethiopia
– sequence: 7
  givenname: Azeb Tadesse
  surname: Argaw
  fullname: Argaw, Azeb Tadesse
  organization: Armauer Hansen Research Institute, Addis Ababa, Ethiopia
– sequence: 8
  givenname: Marta
  surname: Janer
  fullname: Janer, Marta
  organization: Institute for Systems Biology, Fred Hutchinson Cancer Research Center, Seattle
– sequence: 9
  givenname: Lue Ping
  surname: Zhao
  fullname: Zhao, Lue Ping
  organization: Quantitative Genetic Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle
– sequence: 10
  givenname: Gilla
  surname: Kaplan
  fullname: Kaplan, Gilla
  organization: Public Health Research Institute, Laboratory of Mycobacterial Immunity and Pathogenesis, University of Medicine and Dentistry of New Jersey, Newark
– sequence: 11
  givenname: Alan
  surname: Aderem
  fullname: Aderem, Alan
  organization: Institute for Systems Biology, Fred Hutchinson Cancer Research Center, Seattle
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20028701$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18177245$$D View this record in MEDLINE/PubMed
BookMark eNqFkl2LEzEYhYOsuN1V_4EyXigKjuZrkvRGKEVdoaiUCrI3IZt5x2Y3MxmT6Wr_vSlTu34gXiVwnpycvCcn6KgLHSB0n-AXBCvxsqJcKHULTUjFZCkEYUdogjGlJVHT6TE6SekSY8yZkHfQMVFESsqrCTpfBe_LhbuCYgkW-iHEghZPV4slfVZ8DH7bhtivXWpTMYtQzFIK1pkB6uKbG9b5zDXEZHzeGDu40BWuKxbQx5C2d9HtxvgE9_brKfr05vVqflYuPrx9N58tSpujDmXNwV40pmmqSlrAjHKpBCVAamtkzTkHJg0TRhkLvAYqgAGV0gghDKkZY6fo1ejbby5aqC10QzRe99G1Jm51ME7_rnRurb-Ea81wHsK0ygZP9gYxfN1AGnTrkgXvTQdhk7TEFCtF-H9BiikjrNqBD3-NdMjyc-4ZeLwHTLLGN9F01qUDR3NzSmJyc6PNE00RmhsrrHfF67H4DD7_A7RuMLtG8pOd_xt_NOJh0__b8sHIXKb8Kw4Uw1hJUYmsl6Pu0gDfD7qJV1pIJit99vlcz6l8PyfLqabsBzGwz-c
CODEN JIDIAQ
CitedBy_id crossref_primary_10_1371_journal_pone_0175180
crossref_primary_10_3390_molecules200815392
crossref_primary_10_1128_MMBR_00025_10
crossref_primary_10_1590_0074_02760160366
crossref_primary_10_1016_j_inhe_2011_09_006
crossref_primary_10_3389_fimmu_2024_1298749
crossref_primary_10_3389_fmed_2022_865330
crossref_primary_10_3389_fimmu_2018_01223
crossref_primary_10_1002_jgm_2971
crossref_primary_10_1146_annurev_immunol_030409_101335
crossref_primary_10_1371_journal_pntd_0004345
crossref_primary_10_3389_fgene_2022_952219
crossref_primary_10_1016_j_antinf_2012_09_001
crossref_primary_10_1371_journal_pone_0058687
crossref_primary_10_2217_fmb_10_173
crossref_primary_10_1007_s00439_012_1153_7
crossref_primary_10_1093_infdis_jis208
crossref_primary_10_2165_11311110_000000000_00000
crossref_primary_10_1111_j_1365_3083_2012_02681_x
crossref_primary_10_1155_2012_415057
crossref_primary_10_1155_2019_3405103
crossref_primary_10_1097_QCO_0b013e32833c2209
crossref_primary_10_3109_08830185_2013_777064
crossref_primary_10_1590_S0074_02762012000900028
crossref_primary_10_1016_j_jdermsci_2016_01_001
crossref_primary_10_3389_fmed_2023_1233220
crossref_primary_10_1016_j_smim_2018_06_003
crossref_primary_10_1371_journal_pone_0024370
crossref_primary_10_1590_S0074_02762012000900020
crossref_primary_10_1128_IAI_00816_09
crossref_primary_10_1093_infdis_jir521
crossref_primary_10_1371_journal_pntd_0001869
crossref_primary_10_2119_molmed_2009_00097
crossref_primary_10_3389_fphar_2024_1361641
crossref_primary_10_1016_j_intimp_2018_03_002
crossref_primary_10_1111_j_1365_2133_2012_10891_x
crossref_primary_10_1590_0074_02760180274
crossref_primary_10_1038_gene_2011_49
crossref_primary_10_1371_journal_pgen_1003578
crossref_primary_10_2217_fmb_11_39
crossref_primary_10_1016_j_biopha_2012_05_001
crossref_primary_10_2217_pgs_09_121
crossref_primary_10_3109_10408363_2011_641517
crossref_primary_10_1016_j_jdermsci_2008_11_001
crossref_primary_10_3389_fmed_2021_713143
crossref_primary_10_1111_j_1365_4632_2009_04111_x
crossref_primary_10_1016_j_dld_2012_08_006
crossref_primary_10_1186_1297_9716_44_50
crossref_primary_10_1016_j_meegid_2017_03_015
crossref_primary_10_4103_AJPD_AJPD_8_24
crossref_primary_10_1097_INF_0b013e31818de21e
crossref_primary_10_1186_1475_2875_8_50
crossref_primary_10_1038_nrd3087
crossref_primary_10_1051_medsci_2010263281
crossref_primary_10_1016_j_clindermatol_2014_10_001
crossref_primary_10_1517_17530059_2013_786039
crossref_primary_10_3390_ani11071912
crossref_primary_10_1007_s10875_012_9770_4
crossref_primary_10_1371_journal_pntd_0000231
crossref_primary_10_1007_s00439_019_02087_5
crossref_primary_10_1371_journal_pntd_0002015
crossref_primary_10_1016_j_patbio_2013_03_003
crossref_primary_10_1016_j_vetimm_2010_06_015
crossref_primary_10_1016_S0011_393X_10_80005_0
crossref_primary_10_1093_carcin_bgn262
crossref_primary_10_1177_00494755231210724
crossref_primary_10_1371_journal_pone_0029747
crossref_primary_10_1016_j_humimm_2010_07_001
crossref_primary_10_1016_j_mehy_2011_10_022
crossref_primary_10_1016_j_vetimm_2008_12_007
crossref_primary_10_4103_ejdv_ejdv_50_23
crossref_primary_10_1097_SHK_0b013e3181eb45b3
crossref_primary_10_1016_j_clindermatol_2015_10_005
crossref_primary_10_1007_s00439_013_1273_8
crossref_primary_10_1128_IAI_00121_12
crossref_primary_10_1016_j_clindermatol_2014_07_005
crossref_primary_10_1186_1471_2156_10_21
crossref_primary_10_3389_fimmu_2018_00518
crossref_primary_10_3390_tropicalmed8100473
crossref_primary_10_1136_bmjopen_2013_004239
crossref_primary_10_1007_s10096_009_0746_0
crossref_primary_10_1590_S0365_05962011000400013
crossref_primary_10_1093_hmg_ddt286
crossref_primary_10_1016_j_abd_2021_08_006
crossref_primary_10_3389_fmed_2021_694376
crossref_primary_10_1111_j_1365_4632_2011_04961_x
crossref_primary_10_1007_s12026_015_8640_6
crossref_primary_10_1093_infdis_jit133
crossref_primary_10_1016_j_humimm_2013_04_009
crossref_primary_10_1016_S0001_4079_19_32064_3
crossref_primary_10_1097_MAJ_0b013e318232a6cf
crossref_primary_10_1186_1475_2875_11_47
crossref_primary_10_1080_08830185_2020_1851370
crossref_primary_10_1155_2011_923943
crossref_primary_10_3389_fimmu_2018_01674
crossref_primary_10_1038_nrd3203
crossref_primary_10_1093_infdis_jiu612
crossref_primary_10_3389_fimmu_2015_00658
crossref_primary_10_1590_abd1806_4841_20142450
crossref_primary_10_1371_journal_pgen_1006637
crossref_primary_10_1016_j_micinf_2012_03_004
crossref_primary_10_1073_pnas_1901805116
crossref_primary_10_1155_2013_459169
crossref_primary_10_1586_1744666X_2015_1012501
Cites_doi 10.1016/S0928-8244(03)00342-0
10.1038/nrg1916
10.1038/86958
10.1086/315174
10.1007/s00439-004-1249-9
10.1111/j.1399-0039.1997.tb02731.x
10.1038/nri1246
10.1016/S1473-3099(07)70185-8
10.1038/sj.gene.6363926
10.1086/519693
10.1385/IR:28:2:109
10.1016/j.cell.2006.02.015
10.1073/pnas.0409831102
10.4049/jimmunol.170.7.3451
10.1126/science.1925582
10.1086/514853
10.1183/09031936.03.00061703
10.1038/nature02761
10.1038/nature02326
10.1128/CMR.19.2.338-381.2006
10.1146/annurev.immunol.20.081501.125851
10.1111/j.1574-695X.2001.tb01586.x
10.1093/nar/gkh005
10.1126/science.1681588
10.1038/sj.gene.6364274
10.1086/513830
10.4049/jimmunol.149.4.1470
10.1086/517282
10.1002/gepi.1370120107
10.1038/nm864
ContentType Journal Article
Copyright Copyright 2007 Infectious Diseases Society of America
2008 by the Infectious Diseases Society of America 2008
2008 INIST-CNRS
2008 by the Infectious Diseases Society of America. All rights reserved. 2008
Copyright_xml – notice: Copyright 2007 Infectious Diseases Society of America
– notice: 2008 by the Infectious Diseases Society of America 2008
– notice: 2008 INIST-CNRS
– notice: 2008 by the Infectious Diseases Society of America. All rights reserved. 2008
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
C1K
H94
7X8
5PM
DOI 10.1086/524688
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

AIDS and Cancer Research Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1537-6613
EndPage 261
ExternalDocumentID PMC3077295
18177245
20028701
10_1086_524688
10.1086/524688
30087656
ark_67375_HXZ_C27NC1R9_2
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Ethiopia
GeographicLocations_xml – name: Ethiopia
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: U54 AI054523
– fundername: NIAID NIH HHS
  grantid: AI25032
– fundername: NIAID NIH HHS
  grantid: AI22616
– fundername: NIAID NIH HHS
  grantid: R37 AI025032
– fundername: NIAID NIH HHS
  grantid: R01 AI032972
– fundername: NIAID NIH HHS
  grantid: R01 AI025032
– fundername: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
  grantid: R01 AI025032-24 || AI
– fundername: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
  grantid: U54 AI054523-01 || AI
– fundername: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
  grantid: R01 AI032972-20 || AI
GroupedDBID ---
-DZ
-~X
..I
.2P
.I3
.XZ
.ZR
08P
0R~
123
1TH
29K
2AX
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
ABBHK
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPQP
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACGFO
ACGFS
ACGOD
ACHIC
ACPRK
ACUFI
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADQXQ
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFZL
AFIYH
AFOFC
AFXAL
AFYAG
AGINJ
AGKEF
AGORE
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQVQM
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BSCLL
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
EBS
ECGQY
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HQ3
HTVGU
HW0
HZ~
IH2
IOX
IPSME
J21
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
MHKGH
MJL
ML0
N4W
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TR2
W2D
W8F
WH7
X7H
YAYTL
YKOAZ
YXANX
~91
AAYOK
AASNB
ADACV
ADJQC
ADRIX
AFXEN
DOOOF
ESX
JSODD
M49
AAYXX
CITATION
.55
.GJ
1KJ
3O-
41~
AAFWJ
AAPGJ
AAWDT
ABDPE
ABSMQ
ACFRR
ACPQN
ACUTJ
ACVCV
ACZBC
ADMTO
AEKPW
AFFQV
AFHKK
AFQQW
AFSHK
AGKRT
AGMDO
AHGBF
AI.
AJDVS
APJGH
AQDSO
AQKUS
AVNTJ
BZKNY
EIHJH
IQODW
J5H
MBLQV
MVM
NEJ
OBFPC
O~Y
P0-
TMA
VH1
X7M
Y6R
ZE2
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
C1K
H94
7X8
5PM
ID FETCH-LOGICAL-c537t-d4ecbfaff557ce032478621e1dca7d444e37a36a8ace4de26e3e277a666a1d333
ISSN 0022-1899
IngestDate Thu Aug 21 14:12:06 EDT 2025
Sat Sep 27 16:48:09 EDT 2025
Sun Sep 28 10:49:55 EDT 2025
Fri May 30 11:01:06 EDT 2025
Mon Jul 21 09:14:52 EDT 2025
Thu Apr 24 23:04:10 EDT 2025
Tue Jul 01 03:23:59 EDT 2025
Wed Sep 11 04:51:03 EDT 2024
Fri Jun 20 02:32:04 EDT 2025
Sat Sep 20 11:01:42 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Infection
Skin disease
Bacteriosis
Leprosy
Toll like receptor
Mycobacterial infection
Leprosy reaction
Polymorphism
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c537t-d4ecbfaff557ce032478621e1dca7d444e37a36a8ace4de26e3e277a666a1d333
Notes ark:/67375/HXZ-C27NC1R9-2
Present affiliations: Centre for Infections, Health Protection Agency, London, United Kingdom (M.R.S.); American Leprosy Missions, Greenville, South Carolina (P.S.); Department of Medicine, Karolinska Institute, Stockholm, Sweden (S.B.); Mount Sinai School of Medicine, New York, New York (A.T.A.).
istex:335E27CF66A6C07B7A6BAED5BBD9B84721CF6200
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/jid/article-pdf/197/2/253/18051290/197-2-253.pdf
PMID 18177245
PQID 20231354
PQPubID 23462
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3077295
proquest_miscellaneous_70208814
proquest_miscellaneous_20231354
pubmed_primary_18177245
pascalfrancis_primary_20028701
crossref_primary_10_1086_524688
crossref_citationtrail_10_1086_524688
oup_primary_10_1086_524688
jstor_primary_30087656
istex_primary_ark_67375_HXZ_C27NC1R9_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-01-15
PublicationDateYYYYMMDD 2008-01-15
PublicationDate_xml – month: 01
  year: 2008
  text: 2008-01-15
  day: 15
PublicationDecade 2000
PublicationPlace Chicago, IL
PublicationPlace_xml – name: Chicago, IL
– name: United States
PublicationTitle The Journal of infectious diseases
PublicationTitleAbbrev The Journal of Infectious Diseases
PublicationTitleAlternate The Journal of Infectious Diseases
PublicationYear 2008
Publisher The University of Chicago Press
University of Chicago Press
Publisher_xml – name: The University of Chicago Press
– name: University of Chicago Press
References rf25_321
rf36_331
Rajalingam R (rf33_328) 1997; 49
rf14_310
rf37_332
rf2_298
rf30_325
rf18_314
Saunderson P (rf19_315) 2000; 71
Abel L (rf34_329) 1998; 177
rf26_322
rf15_311
rf12_308
rf3_299
rf9_305
Ridley DS (rf1_297) 1966; 34
Roy S (rf32_327) 1997; 176
rf10_306
rf17_313
rf28_324
rf38_333
Schreuder PA (rf6_302) 1998; 66
rf27_323
rf4_300
rf8_304
de Rijk AJ (rf20_316) 1994; 65
Jopling WH (rf21_317) 1981; 52
rf16_312
rf31_326
Yamamura M (rf5_301) 1992; 149
de Rijk AJ (rf22_318) 1994; 65
Bochud P-Y (rf13_309) 2003; 170
rf11_307
rf24_320
rf35_330
rf7_303
Saunderson P (rf23_319) 2000; 71
References_xml – ident: rf15_311
  doi: 10.1016/S0928-8244(03)00342-0
– volume: 34
  start-page: 255
  year: 1966
  ident: rf1_297
  publication-title: Int J Lepr Other Mycobact Dis
– ident: rf38_333
  doi: 10.1038/nrg1916
– volume: 65
  start-page: 320
  year: 1994
  ident: rf22_318
  publication-title: Lepr Rev
– ident: rf9_305
  doi: 10.1038/86958
– ident: rf36_331
  doi: 10.1086/315174
– volume: 65
  start-page: 305
  year: 1994
  ident: rf20_316
  publication-title: Lepr Rev
– ident: rf27_323
  doi: 10.1007/s00439-004-1249-9
– volume: 71
  start-page: 273
  year: 2000
  ident: rf19_315
  publication-title: Lepr Rev
– volume: 49
  start-page: 168
  year: 1997
  ident: rf33_328
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.1997.tb02731.x
– ident: rf12_308
  doi: 10.1038/nri1246
– ident: rf17_313
  doi: 10.1016/S1473-3099(07)70185-8
– ident: rf7_303
  doi: 10.1038/sj.gene.6363926
– ident: rf18_314
  doi: 10.1086/519693
– volume: 66
  start-page: 159
  year: 1998
  ident: rf6_302
  publication-title: Reactions. Int J Lepr Other Mycobact Dis
– ident: rf8_304
  doi: 10.1385/IR:28:2:109
– ident: rf10_306
  doi: 10.1016/j.cell.2006.02.015
– ident: rf26_322
  doi: 10.1073/pnas.0409831102
– volume: 170
  start-page: 3451
  year: 2003
  ident: rf13_309
  publication-title: J Immunol
  doi: 10.4049/jimmunol.170.7.3451
– ident: rf3_299
  doi: 10.1126/science.1925582
– ident: rf24_320
  doi: 10.1086/514853
– ident: rf14_310
  doi: 10.1183/09031936.03.00061703
– ident: rf11_307
  doi: 10.1038/nature02761
– volume: 52
  start-page: 273
  year: 1981
  ident: rf21_317
  publication-title: Lepr Rev
– ident: rf37_332
  doi: 10.1038/nature02326
– ident: rf2_298
  doi: 10.1128/CMR.19.2.338-381.2006
– ident: rf31_326
  doi: 10.1146/annurev.immunol.20.081501.125851
– ident: rf25_321
  doi: 10.1111/j.1574-695X.2001.tb01586.x
– ident: rf28_324
  doi: 10.1093/nar/gkh005
– ident: rf4_300
  doi: 10.1126/science.1681588
– ident: rf16_312
  doi: 10.1038/sj.gene.6364274
– volume: 177
  start-page: 133
  year: 1998
  ident: rf34_329
  publication-title: J Infect Dis
  doi: 10.1086/513830
– volume: 149
  start-page: 1470
  year: 1992
  ident: rf5_301
  publication-title: J Immunol
  doi: 10.4049/jimmunol.149.4.1470
– volume: 71
  start-page: 309
  year: 2000
  ident: rf23_319
  publication-title: Lepr Rev
– volume: 176
  start-page: 530
  year: 1997
  ident: rf32_327
  publication-title: J Infect Dis
  doi: 10.1086/517282
– ident: rf35_330
  doi: 10.1002/gepi.1370120107
– ident: rf30_325
  doi: 10.1038/nm864
SSID ssj0004367
Score 2.2831402
Snippet Background. Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may...
Background. Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may...
Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may undergo...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
oup
jstor
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 253
SubjectTerms Adolescent
Adult
Bacteria
Bacterial diseases
Biological and medical sciences
Case-Control Studies
Child
Child, Preschool
Ethiopia
Ethnic groups
Ethnicity
Female
Genetic Predisposition to Disease
Haplotypes
Human bacterial diseases
Humans
Infant
Infant, Newborn
Infectious diseases
Leprosy
Leprosy - ethnology
Leprosy - genetics
Leprosy - immunology
Leprosy - physiopathology
Linkage Disequilibrium
Male
Medical genetics
Medical sciences
Microbial genetics
Microsatellite Repeats
Microsatellites
Middle Aged
Polymorphism, Genetic
Polymorphism, Single Nucleotide
rev genes
Toll like receptors
Toll-Like Receptor 2 - genetics
Tropical bacterial diseases
Title Toll-Like Receptor 2 (TLR2) Polymorphisms Are Associated with Reversal Reaction in Leprosy
URI https://api.istex.fr/ark:/67375/HXZ-C27NC1R9-2/fulltext.pdf
https://www.jstor.org/stable/30087656
https://www.ncbi.nlm.nih.gov/pubmed/18177245
https://www.proquest.com/docview/20231354
https://www.proquest.com/docview/70208814
https://pubmed.ncbi.nlm.nih.gov/PMC3077295
Volume 197
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1537-6613
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004367
  issn: 0022-1899
  databaseCode: KQ8
  dateStart: 19970401
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals Online
  customDbUrl:
  eissn: 1537-6613
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0004367
  issn: 0022-1899
  databaseCode: DIK
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1537-6613
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004367
  issn: 0022-1899
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqTSAkhGAw6IDhB0CgKlPj-JI-Vu1QC92A0opuL5GTOKLaSKdeEOOH8Hs5juOk2YXbS1QlR6mV7_Pl2N85B6HnbuRGESxUHZ_TpkO1KKfFw8jxeJjENAn1HKjVFoe8N6ZvJ2xSq_1cUy2tluFe9OPKuJL_QRXuAa46SvYfkC1eCjfgN-ALV0AYrn-HMYDoDKYnuvaClqfM5g2il4yjwZBod__D7BRce_iS08XXRaM9VwUaVnQ-VFqWkSXYz4uGT9PGQMGwuqic95YRZHmSCSPhWi3sCU-52_6-0xt3s8UpzLhz5Rx9Kx_22p8PS1lSKVYEOgz3D0zATUnXT_1ut_9x3M82bfcaw1V4Xtmk0Po4x4RpriW8_Z3IxAYWuL6pl1QMzka9m7OQrA-1JslwPmsTk9L90oTQzM6nGKHcVA-sZty-MBMW-kStXIGBDLzqTSI415Uxuv13Zbytx4XNQq8bvFazyvxTZZGzqfvrd6t3tYGUt8_kAnphYsqnXOXfXJTprq17RnfRnRx03Dbsu4dqKt1CN0wJ0_MtdPMgF2fcR8cFHbGlIyb4lSbja1yhIrxN4ZKKWFMRWypiS0U8TXFOxQdo_GZ_1Ok5eekOJ2KeWDoxVVGYyCRhTOiKdIQKcJ1d5caRFDGlVHlCelz6MlI0VoQrTxEhJDjT0o09z9tGG-ksVY8QprCGDiXlsc8o9WlTZk59k8imVIlirTp6Yb91EOV57XV5ldMg01f4PDCY1NGzwu7MZHK5ZPEyg6p4LOcnWvcoWNCbHAcdIg477rAVkDrazrAsDL0ssyPjdbQD4F77-t0K5oWZZRu00JIggEFen9zJVEFXBgtwwzxGr7cQutiu74LFQ0OashG-Cx40ZXUkKnQqDHSC-eqTdPolSzQP8z_43mznTw1_jG6Vnf4J2ljOV-oprNWX4W7WcX4BXvHmnw
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Toll-Like+Receptor+2+%28TLR2%29+Polymorphisms+Are+Associated+with+Reversal+Reaction+in+Leprosy&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=BOCHUD%2C+Pierre-Yves&rft.au=HAWN%2C+Thomas+R&rft.au=ADEREM%2C+Alan&rft.au=SIDDIQUI%2C+M.+Ruby&rft.date=2008-01-15&rft.pub=University+of+Chicago+Press&rft.issn=0022-1899&rft.volume=197&rft.issue=2&rft.spage=253&rft.epage=261&rft_id=info:doi/10.1086%2F524688&rft.externalDBID=n%2Fa&rft.externalDocID=20028701
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon